Medix Explorer

Medix Explorer offers a new dimension in Detail Aid Testing, providing qualitative and quantitative solutions via reliable and robust samples.

Medix Explorer is individually designed to meet client’s requirements.

Medix Explorer offers a readily available sample of UK General Practitioners and Hospital Specialists drawn from our membership of over 13,000 doctors.

Medix Explorer provides full results from 200 GPs within 48 hours of questionnaire agreement and receipt of materials. Results from 50 Hospital Specialists are typically available within 10-14 days.

Medix Explorer can also test the views of the medical representatives who are going to use the Detail Aid.

Medix Explorer is priced on an individual study basis according to the complexity of the Detail Aid and the total number of questions.

What key messages are communicated?
How effectively is each of the key messages communicated?
In what way could the key messages be communicated more effectively?
To what extent are the overall communication objectives met?
In what way could the information flow be improved?
How does the data presented compare with other products / classes of drugs in the same therapy area?

Methodology

Medix Explorer is an innovative and reliable tool to test Detail Aids.

Respondents may either view the Detail Aid in its entirety or alternatively on a page by page basis. Our “time out” facility allows individual pages to be viewed for a limited period, e.g. 20 seconds, or for as long as the respondent requires.

A written commentary can be provided in conjunction with each page.

Every doctor receives the same message in a controlled environment.

Open ended results are typed and complete, yielding robust qualitative assessments, with the reliability of a quantitative sample.

Pre-coded questions are carefully viewed by respondents rather than read out by an interviewer.

Doctors respond entirely at their own pace in a relaxed environment at a time and place convenient to them.

The acceptance rate is typically around 98%, avoiding sampling issues associated with a larger number of non-responders. Acceptance rates are published in each report.

For further information please telephone
Ross Hailstone on 01763 853303
or email: rh@medixglobal.com